Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8534 ...

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality. I n 2024, a woman ...

A universal vascular graft made from stem cell-derived arterial endothelial cells could advance the field of vascular bypass ...

A man who donated his stem cells in a bid to save the life of a critically ill patient has said his work at an NHS hospital ...

aGvHD is a common complication of allogeneic haematopoietic stem cell transplantation (alloHCT) and is a detrimental ...

Small-diameter artery grafts engineered from pluripotent stem cells maintain 100% patency in an allogeneic rhesus macaque ...

PranaX Corporation ( an emerging regenerative medicine biotechnology company, today announced that it has licensed exosome technology from The University of Texas MD Anderson Cancer Center to develop ...

Alpha Teknova (TKNO) and Pluristyx announced that the companies are collaborating to produce and commercialize Pluristyx’s PluriFreeze product ...

In this episode of Targeted Talks, Alfred L. Garfall, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for seriou ...

The frantic race to save 22-year-old Mia Preston seemed like a mission impossible, involving an epic 13,000km trek and a one-in-50-year cyclone.